APA (7th ed.) Citation

YH, F., KM, N., CY, T., AC, H., CH, T., WC, C., . . . LI, L. (2026). Modulating metabolic signatures to mitigate cabozantinib resistance in FLT3-ITD acute myeloid leukemia cell models. Cell death discovery, 12(1), 98. https://doi.org/10.1038/s41420-026-02957-8

Chicago Style (17th ed.) Citation

YH, Fu, Ng KM, Tseng CY, Huang AC, Tu CH, Chen WC, Lang PC, Chien HF, and Lin LI. "Modulating Metabolic Signatures to Mitigate Cabozantinib Resistance in FLT3-ITD Acute Myeloid Leukemia Cell Models." Cell Death Discovery 12, no. 1 (2026): 98. https://doi.org/10.1038/s41420-026-02957-8.

MLA (9th ed.) Citation

YH, Fu, et al. "Modulating Metabolic Signatures to Mitigate Cabozantinib Resistance in FLT3-ITD Acute Myeloid Leukemia Cell Models." Cell Death Discovery, vol. 12, no. 1, 2026, p. 98, https://doi.org/10.1038/s41420-026-02957-8.